Global Non-Opioid Pain Treatment Market is Expected to Reach a Market Value of USD 4.99 billion by 2027

Non-Opioid Pain Treatment Market is estimated to grow at 3.15% for 2020-2027 with factors such as high cost of drugs along with easy availability of alternative treatment which will hamper the growth of the market in emerging economies.

Non-opioid pain treatment market has shown an exceptional penetration in developed economies in North America. Growing number of clinical trials along with rising levels of funds from government as well as private organizations is helping in driving the growth of the non-opioid pain treatment market.

Non-Opioid Pain Treatment Market Scenario

According to Data Bridge Market Research the non-opioid pain treatment market is attaining a significant growth in developing economies during the forecast period of 2020-2027 due to factors such as prevalence of better healthcare facilities along with rising geriatric population, increasing occurrences of chronic diseases, rising research activities which will help in boosting the growth of the market. 

Now the question is which are the other regions that non-opioid pain treatment market is targeting? Data Bridge Market Research has estimated a large growth in Asia-Pacific non-opioid pain treatment market in the forecast period of 2020-2027. The Data bridge market research new reports highlight the major growth factors and opportunities in the non-opioid pain treatment market.

For more analysis on the non-opioid pain treatment market request for a briefing with our analysts

Non-Opioid Pain Treatment Market Development in 2020

  • In February 2020, Q BioMed Inc launched non-opioid drug Strontium89 which is approved by the FDA and used to provide relieve persistent pain of the patients suffering from cancer and other diseases. The product launch will help in reaching the global level in the market.

Scope of the Non-Opioid Pain Treatment Market

Non-opioid pain treatment market is segmented on the basis of countries into U.S., Canada, Mexico in North America, Brazil, Argentina, Rest of South America as a part of South America, Germany, France, U.K., Italy, Spain, Netherlands, Belgium, Russia, Turkey, Switzerland, Rest of Europe in Europe, China, Japan, India, Australia, Singapore, Thailand, Malaysia, South Korea, Indonesia, Philippines, Rest of Asia-Pacific (APAC) as a part of Asia-Pacific (APAC), U.A.E, Egypt, Saudi Arabia, South Africa, Israel,  Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

  • All country based analysis of the non-opioid pain treatment market is further analyzed based on maximum granularity into further segmentation. On the basis of products, the market is segmented into medical cannabis, menthol- containing, omega 3 fatty acid containing, botulinum toxins, and capsaicin derived. Based on drug type, the market is segmented into acetaminophen, non-steroidal anti-inflammatory drugs, corticosteroids, anticonvulsants, and serotoninnorepinephrine reuptake inhibitor antidepressants. Based on distribution channel, the market is segmented into hospitals pharmacies, retail pharmacies, drug stores, and mail order pharmacies. The therapeutic applications covered for the report are orthopaedic & musculoskeletal pain, neuropathic pain, cancer pain, and other pain.
  • Non-opioid pain treatment is used to provide pain relief treatment through medical cannabis, capsaicin derived, botulinum toxins, and others. This type of treatment is used in applications of neuropathic pain, musculoskeletal pain, cancer pain, and others.

To know more about the study

Key Pointers Covered in the Non-Opioid Pain Treatment Market Industry Trends and Forecast to 2027

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Key Market Competitors Covered in the report

  • Pfizer Inc.
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries Ltd.
  • Regeneron Pharmaceuticals
  • Centrexion Therapeutics
  • Novartis AG
  • US WorldMeds, LLC.
  • GW Pharmaceuticals plc.
  • Cara Therapeutics
  • Anodyne Pain,LLC

Above are the key players covered in the report, to know about more and exhaustive list of Non-Opioid Pain Treatment companies contact us

Research Methodology: Global Non-Opioid Pain Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@